Aggressive chemotherapy in frail patients with diffuse large B-cell lymphoma: The role of pegylated liposomal doxorubicin
Journal of Hematological Malignancies · 2012
DOI: 10.5430/jhm.v2n2p5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematological Malignancies, 2012. Verfasst von Natividad Neri und 5 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Neri, N., Avilés, A., Schmitt, C. J., Scherrer-Crosbie, M., Smith, L. A., & Verma, S. (2012). Aggressive chemotherapy in frail patients with diffuse large B-cell lymphoma: The role of pegylated liposomal doxorubicin. Journal of Hematological Malignancies. https://doi.org/10.5430/jhm.v2n2p5
Vancouver
Neri N, Avilés A, Schmitt CJ, Scherrer-Crosbie M, Smith LA, Verma S. Aggressive chemotherapy in frail patients with diffuse large B-cell lymphoma: The role of pegylated liposomal doxorubicin. Journal of Hematological Malignancies. 2012. doi:10.5430/jhm.v2n2p5
BibTeX
@article{Neri2012,
author = {Neri, Natividad and Avilés, Agustin and Schmitt, Christian Johannes and Scherrer-Crosbie, Marielle and Smith, Lesley A and Verma, S.},
title = {Aggressive chemotherapy in frail patients with diffuse large B-cell lymphoma: The role of pegylated liposomal doxorubicin},
journal = {Journal of Hematological Malignancies},
year = {2012},
doi = {10.5430/jhm.v2n2p5}
}
EUVIMED